TransMedics Group, Inc. Made Headway

TransMedics Group, Inc. (TMDX:NASDAQ) jumped higher at $60.76, representing a gain of 51.2%. On Tue, Nov 07, 2023, TMDX:NASDAQ hit a New 2-Week High of $60.76. The stock got featured on our News Catalysts scanner on Mon, Nov 06, 2023 at 06:46 PM in the 'EARNINGS' category. From Tue, Oct 24, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days

About TransMedics Group, Inc. (TMDX:NASDAQ)

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the OCS to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.